183***1911
Shanghai Kaijing Biotechnology Co., Ltd. was established in 2013. It is a company mainly focused on research and development transformation, focusing on the research and production of antigen antibodies. The company has built a monoclonal antibody discovery platform based on fully automated high-throughput hybridoma and single B cell technology, providing customers with excellent products.
购物车